Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation

INTRODUCTION: The mortality of coronavirus disease 2019 (COVID-19) is frequently driven by an injurious immune response characterized by the development of acute respiratory distress syndrome (ARDS), endotheliitis, coagulopathy, and multi-organ failure. This spectrum of hyperinflammation in COVID-19...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Expert Rev Clin Immunol
Asıl Yazarlar: Amigues, Isabelle, Pearlman, Alexander H, Patel, Aarat, Reid, Pankti, Robinson, Philip C., Sinha, Rashmi, Kim, Alfred Hj, Youngstein, Taryn, Jayatilleke, Arundathi, Konigon, Maximilian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879704/
https://ncbi.nlm.nih.gov/pubmed/33146561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1744666X.2021.1847084
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller